ALKBH5 gene polymorphisms and risk of neuroblastoma in Chinese children from Jiangsu Province
Cancer Innovation · 2024
DOI: 10.1002/cai2.103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Innovation, 2024. Verfasst von Qian Guan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Diseas…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Postdoctoral Science Foundation of Jiangsu Province, National Natural Science Foundation of China.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Neuroblastoma is one of the most common extracranial malignant solid tumors in children. AlkB homolog 5 (ALKBH5) is an RNA N6‐methyladenosine (m6A) demethylase that plays a critical role in tumorigenesis and development. We assessed the association between single nucleotide polymorphisms (SNPs) in ALKBH5 and the risk of neuroblastoma in a case‐control study including 402 patients and 473 non‐cancer controls.
Methods
Genotyping was determined by the TaqMan method. The association between ALKBH5 polymorphisms (rs1378602 and rs8400) and the risk of neuroblastoma was evaluated using the odds ratio (OR) and 95% confidence interval (CI).
Results
We found no strong association of ALKBH5 rs1378602 and rs8400 with neuroblastoma risk. Further stratification analysis by age, sex, primary site, and clinical stage showed that the rs1378602 AG/AA genotype was associated with a lower risk of neuroblastoma in males (adjusted OR = 0.58, 95% CI = 0.35–0.97, p = 0.036) and children with retroperitoneal neuroblastoma (adjusted OR = 0.58, 95% CI = 0.34–0.98, p = 0.040).
Conclusions
ALKBH5 SNPs do not seem to be associated with neuroblastoma risk. More studies are required to confirm this negative result and reveal the relationship between gene polymorphisms of the m6A modifier ALKBH5 and neuroblastoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangdong Provincial Clinical Research Center for Child Health, Gua…
- Department of Pathology Children's Hospital of Nanjing Medical University Nanjing Jiangsu China.
- Department of Clinical Laboratory, Biobank Harbin Medical University Cancer Hospital Harbin Heilongjiang China.
- Laboratory Animal Center, School of Chemical Biology and Biotechnology Peking University Shenzhen Graduate School Shenzhen Guangdong China.
ORCID-Profile: Zhenjian Zhuo
Förderung
- Postdoctoral Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
Zitieren
APA
Guan, Q., Zhang, X., Liu, J., Zhou, C., Zhu, J., Wu, H., Zhuo, Z., & He, J. (2024). ALKBH5 gene polymorphisms and risk of neuroblastoma in Chinese children from Jiangsu Province. Cancer Innovation. https://doi.org/10.1002/cai2.103
Vancouver
Guan Q, Zhang X, Liu J, Zhou C, Zhu J, Wu H, et al. ALKBH5 gene polymorphisms and risk of neuroblastoma in Chinese children from Jiangsu Province. Cancer Innovation. 2024. doi:10.1002/cai2.103
BibTeX
@article{Guan2024,
author = {Guan, Qian and Zhang, Xinxin and Liu, Jiabin and Zhou, Chunlei and Zhu, Jinhong and Wu, Haiyan and Zhuo, Zhenjian and He, Jing},
title = {ALKBH5 gene polymorphisms and risk of neuroblastoma in Chinese children from Jiangsu Province},
journal = {Cancer Innovation},
year = {2024},
doi = {10.1002/cai2.103}
}
EUVIMED